To read this content please select one of the options below:

Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical company

Anders Ingelgård (Anders Ingelgård is at the Fenix Research Program, Chalmers University of Technology, Göteborg, Sweden.)
Jonas Roth (Jonas Roth is at the Fenix Research Program, Chalmers University of Technology, Göteborg, Sweden.)
Alexander Styhre (Alexander Styhre is at the Fenix Research Program, Chalmers University of Technology, Göteborg, Sweden.)
A.B. (Rami) Shani (A.B. (Rami) Shani is a Professor of Management at the California Polytechnic University, Orfela College of Business, San Luis Obispo, California, USA.)

The Learning Organization

ISSN: 0969-6474

Article publication date: 1 May 2002

1829

Abstract

This article explores the use of organizational learning mechanisms to create actionable knowledge in a pharmaceutical company. An action research based approach was used to explore the nature and issues associated with fostering the dynamic learning capability within the firm. The results indicate that dynamic learning capability is embedded and influenced by company culture, existing skills and competence, organizational structure, incentives for learning, capacity for continuous change and leadership. It is argued that enabling actionable knowledge creation is a fragile process that has to be managed with care, and is far more complex than the literature suggests.

Keywords

Citation

Ingelgård, A., Roth, J., Styhre, A. and Shani, A.B.(R). (2002), "Dynamic learning capability and actionable knowledge creation: clinical R&D in a pharmaceutical company", The Learning Organization, Vol. 9 No. 2, pp. 65-77. https://doi.org/10.1108/09696470210424015

Publisher

:

MCB UP Ltd

Copyright © 2002, MCB UP Limited

Related articles